Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1123
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSobirova D.R-
dc.contributor.authorAzizova F.X., Ishandjanova S.X., Otajanova A.N., Utepova N.B.-
dc.date.accessioned2021-12-27T09:02:02Z-
dc.date.available2021-12-27T09:02:02Z-
dc.date.issued2021-11-11-
dc.identifier.issn2776-1010-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/1123-
dc.description.abstractThe question of the need to prescribe antibiotic therapy to patients with exacerbation of chronic obstructive pulmonary disease requires justification of the prescription of an antibiotic, taking into account the likelihood of an etiological role of an infectious factor, the possibility of spontaneous remissions, as well as the risk of negative consequences in case of unreasonable prescription (development of microorganism resistance, unwanted side effects, unjustified costs) ... In addition, the large arsenal of modern antibiotics poses the problem of choosing the optimal drug for the doctor. With extreme caution, it is necessary to treat the choice of antibiotic therapy for patients with diabetes mellitus with concomitant chronic obstructive pulmonary disease.en_US
dc.language.isoenen_US
dc.subjectchronic obstructive pulmonary disease, diabetes mellitus, diabetic microangiopathy, microcirculation, lung tissue.en_US
dc.title«Study of changes in pulmonary alveolar epithelium and aerogematic barrier in diabetes mellitus»en_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
433-Article Text-813-1-10-20211117_compressed (1).pdf108.92 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.